← Open Payments lookup

ALLEN CHROMAN: Open Payments

NPI 1578602728 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,754 in 33 payments from 9 companies in 2025. Trend: 2023 $1,221 · 2024 $1,007 · 2025 $3,754

Debt forgiveness: $2,533Food & beverage: $1,202Travel & lodging: $19
CompanyPaymentsAmount
Neuronetics, Inc.1$2,533
Neurocrine BioSciences, Inc.5$410
ABBVIE INC.14$381
Axsome Therapeutics, Inc.1$144
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$138
Takeda Pharmaceuticals U.S.A., Inc.2$55
Lundbeck LLC2$54
E.R. Squibb & Sons, L.L.C.1$24
Supernus Pharmaceuticals, Inc.1$16

Products named: NEUROSTAR TMS THERAPY SYSTEM, INGREZZA, VRAYLAR, Auvelity, CAPLYTA, TRINTELLIX, REXULTI, Qelbree.

Industry payments across CA — which companies pay providers there.